During the past decade, German Heart Center Munich conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "German Heart Center Munich" #1 sponsor was "Charite University, Berlin, Germany" with 2 trials, followed by "Icahn School of Medicine at Mount Sinai" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Biostable Science & Engineering" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "German Heart Center Munich" #1 collaborator was "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 1 trials as a collaborator and "Coordinating Centre for Clinical Trials, Charité" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "German Heart Center Munich" are "Aortic Valve Replacement" (2 trials), "Allogeneic Blood Transfusion" (1 trials), "Aortic Regurgitation" (1 trials), "Aortic Valve Stenosis" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "German Heart Center Munich" in a lesser frequency.

Most popular intervention types in "German Heart Center Munich" are "Device" (7 trials), "Drug" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antiplatelet-only strategy" (1 trials), "Closure, Foramen Ovale" (1 trials), "Experimental: Spironolactone" (1 trials), "HAART 300 Annuloplasty Device" (1 trials) and "Intraaortic balloon pump" (1 trials). Other intervention names were less common.

The vast majority of trials in "German Heart Center Munich" are 14 trials for "All" genders.

Currently, there are NaN active trials in "German Heart Center Munich". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in German Heart Center Munich, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in German Heart Center Munich, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".